Editing Framingham Heart Study (section)

==History==
In 1948, the study was commissioned by the
[[United States Congress]], with multiple communities being considered for study.  The final choice was between Framingham, Massachusetts, and [[Paintsville, Kentucky]]. Framingham was chosen when residents showed more general interest in heart research than Paintsville. Thomas Royle Dawber was director of the study from 1949 to 1966. He was appointed as chief epidemiologist shortly after the start of the project, when it was not progressing well.<ref>{{cite journal | author=Richmond | title=Obituary: Thomas Royle Dawber | journal=BMJ | year=2006 | volume=332 | pages=122 | doi=10.1136/bmj.332.7533.122 | issue=7533| pmc=1326951 }}</ref> The study had been intended to last 20 years; however, interest grew in part due to Dr. Dawber's efforts to promote the study and engage in fundraising after he had been transferred to Boston to accept a chairmanship of preventive medicine. By 1968, it was debated whether the original study had served its purpose and should be terminated as scheduled. A committee gathered and considered that, after 20 years of research, the Framingham study should come to an end, since their hypothesis had been tested and extensive information concerning heart diseases had been gathered. Despite this conclusion, Congress failed to accept the recommendation, instead voting to continue the study. The study has been split into different segments, or "cohorts".{{citation needed|date=May 2023}}

[[William P. Castelli]] is a former director of the Framingham Heart Study.<ref>{{cite journal|year=2004|title=William Peter Castelli, MD: A conversation with the Editor|journal=The American Journal of Cardiology|url=https://www.ajconline.org/article/S0002-9149(04)00790-8/pdf|volume=94|issue=5|pages=609–622|doi=10.1016/j.amjcard.2004.05.025|pmid=15342292 |last1=Castelli |first1=W. P. }}</ref>
* The Original Cohort, founded in 1948, consisted of 5,209 men and women. Requirements for entry were an age between 30 and 62 years at the time of first examination, with no history of heart attack or stroke. Due to lukewarm interest at first, doctors, nurses and healthcare workers volunteered for the study to set an example for patients.
* The Offspring Cohort, founded in 1971, was a second-generation study for which children of the Original Cohort were eligible. Spouses were also eligible if they had become pregnant with or sired two or more children by a participant in the Offspring Cohort.
* The Omni One Cohort, founded in 1994, looked at the possible influence of race and heritage as heart risk factors, as well as the changing racial background of Framingham.
* The Generation Three Cohort, founded in 2002, was a third-generation study consisting of children of the Offspring Cohort and grandchildren of the Original Cohort participants. Minimum age for acceptance was 20 years.
* The Omni Two Cohort, founded in 2003, was a second-generation study involving children of Omni Cohort participants. While the Original Cohort had been spaced over decades, the Omni Cohort had a much shorter generational window. On account of this, participants as young as 13 years of age were eligible for the Omni Two Cohort.